Sir -The above paper by Turunen et al. (1984) provides interesting data about the relative sensitivities of FECA-EIA, an immunological test for human haemoglobin (Hb), and four guaiac tests for the detection of faecal occult blood. The authors also present data on blood loss in 19 patients with colorectal cancer. The observation that blood loss from cancers in the R. hemicolon is greater than that from cancers in the L. hemicolon and rectum confirms our findings (Macrae & St. John, 1982) . However the authors draw the additional conclusion that blood loss is related to tumour stage, incorrectly stating that this is similar to our findings.
The issue about a relationship between blood loss and tumour stage is important as it has implications for the likely situation in early cancers that may be diagnosed in screening programmes.
We have reviewed our data based on 380 twentyfour hour faecal samples obtained from 46 patients with colorectal cancer. For the purposes of comparison, the results have been grouped as in the article by Turunen et al. (Table) . Separate analyses of variance were performed on log-transformed measurements of mean daily blood loss and mean faecal Hb concentration to assess their relationship with tumour site and stage. Blood loss (P<0.001) and Hb concentration (P<0.01) varied significantly with site of tumour. Stage had no effect after fitting site. Furthermore, there was no interaction between 
